New research suggests a common beverage may offer a surprisingly effective tool in the fight against type 2 diabetes, a disease affecting hundreds of millions globally and increasingly diagnosed in younger populations. Scientists have discovered compounds in roasted coffee beans that mirror the effects of acarbose, a commonly prescribed medication for managing blood sugar levels.The study, focusing on previously unknown compounds dubbed cavaldehide A, B, and C, offers a potential pathway toward naturally modulating glucose response through dietary choices and “functional foods.”
A daily cup of coffee may be as effective at managing blood sugar levels as a common diabetes medication, according to new research. The findings offer a potential avenue for improving the lives of the over 400 million people worldwide living with type 2 diabetes, a condition requiring careful blood glucose control.
Researchers directly compared compounds found in roasted Arabica coffee with acarbose, a widely used drug that slows the breakdown of carbohydrates after a meal. The study revealed that coffee inhibits the same digestive enzyme targeted by the medication, helping to limit spikes in blood sugar following food consumption.
Type 2 diabetes develops when the body doesn’t produce enough insulin, or when cells become resistant to its effects, leading to a buildup of glucose in the bloodstream. Uncontrolled blood sugar can lead to serious complications, including heart disease, stroke, kidney failure, vision loss, and nerve damage.
While weight loss and lifestyle changes can help manage or even reverse the condition in some cases, many patients require long-term treatment with medications like insulin, GLP-1 drugs, and acarbose.
The research team identified three compounds in coffee capable of inhibiting alpha-glucosidase, a key enzyme involved in carbohydrate breakdown during digestion. Through a three-stage extraction process, they isolated three previously unknown compounds – named cavaldehide A, B, and C – all of which demonstrated a clear ability to reduce the enzyme’s activity, mirroring the way acarbose works.
“This discovery could pave the way for the development of ‘functional foods’ with natural blood sugar-lowering properties, alongside other health benefits,” researchers said.
Previous large-scale studies have already linked regular coffee consumption to a reduced risk of developing type 2 diabetes, with indications that each additional cup per day may further lower this risk. Research suggests that drinking three to five cups daily is associated with the greatest health benefit.
In the United Kingdom, diabetes is the fastest-growing health crisis, with obesity contributing to a 39% increase in cases of type 2 diabetes among those under 40. This form of the disease, accounting for around 90% of all diabetes cases, is linked to excess weight, unlike type 1 diabetes, which has a genetic origin.
As of 2021–2022, approximately 4.3 million people were living with diabetes in the United Kingdom.
The findings come as experts caution that some patients receiving weight-loss injections – such as Mounjaro and Wegovy, also used to manage diabetes – may need to continue treatment for extended periods. A comprehensive report from the University of Oxford indicated that the significant benefits of these injections, including weight loss and improved heart health, may partially diminish after stopping treatment.
This research adds to a growing body of evidence suggesting that dietary factors can play a significant role in managing blood sugar and preventing the progression of type 2 diabetes. The findings underscore the importance of continued research into natural compounds and their potential therapeutic applications.
